Clinical Trial Supply And Logistics Market To Witness A Significant Growth Of USD 5.4 Billion By 2028


 San Francisco, 5 Nov 2021: The Report Clinical Trial Supply And Logistics Market Size, Share & Trends Analysis Report By Service (Logistics & Distribution, Storage & Retention), By Phase, By End-user, By Therapeutic Area, By Region, And Segment Forecasts, 2021 - 2028

The global clinical trial supply and logistics market size is expected to reach USD 5.4 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.1% from 2021 to 2028. The market growth is attributed to the increasing need to manage clinical trials and innovations and technology advancements in clinical trial supply and logistics services.

However, the COVID-19 pandemic had a negative impact on the market due to restrictions imposed by countries, which led to a 95% reduction in commercial airlines. Besides, clinical trials have increased due to the rising demand for the Covid-19 vaccine. According to the WHO, more than 80 vaccines are currently being studied in clinical trials, with over 180 in the pre-clinical stage. There would be a challenge for logistics related to timelines and access to a large population.

Digitalization tools are required to overcome these challenges for future trials. For instance, a kit with a scannable label can be monitored throughout the supply chain from the kit assembly line to the patient’s home. Machine learning algorithms can take the process a step further by considering various factors across multiple supply chains, such as capacity or hours of service. Radio-frequency identification (RFID) can also aid in the management of shipments required for these clinical trials.

Access Research Report of Clinical Trial Supply And Logistics Market @ https://www.grandviewresearch.com/industry-analysis/clinical-trial-supply-logistics-market-report

Clinical Trial Supply And Logistics Market Report Highlights

  • The logistics and distribution service segment dominated the market in 2020 with a revenue share of over 20.0% owing to an increase in clinical trials as a result of Covid-19
  • Based on phase, the phase III segment dominated the market with a revenue share of over 40.0% in 2020
  • In terms of end-user, the pharmaceuticals segment held the largest revenue share of over 40.0% in 2020. This is due to the investment by companies and the presence of a large number of players in the market
  • By therapeutic area, the cardiovascular diseases segment dominated the market with a revenue share of over 25.0% in 2020 due to an increase in the number of cardiovascular research studies and firms focused on bringing innovative drugs to the market
  • Asia Pacific is anticipated to register the fastest growth rate of 7.8% throughout the forecast period. The region has access to a large and diversified patient pool, cheaper recruitment costs, and favorable policies that make Asia Pacific desirable for clinical trials

List of Key Players of Clinical Trial Supply And Logistics Market

  • Thermo Fisher Scientific (Patheon)
  • Catalent, Inc.
  • Parexel
  • Almac Group
  • Marken
  • Piramal Pharma Solutions 
  • UDG Healthcare
  • DHL
  • FedEx
  • Movianto
  • Packaging Coordinators Inc.

Access Press Release of Clinical Trial Supply And Logistics Market @ https://www.grandviewresearch.com/press-release/global-clinical-trial-supply-logistics-market

 

Comments

Post a Comment

Popular posts from this blog

Asia Pacific PoC Diagnostics Market Growth Opportunities, Industry Analysis And Forecast: Grand View Research Inc.

Image
San Francisco, 18 March 2020 :  The Report   Asia Pacific PoC Diagnostics Market  Analysis And Segment Forecasts To 2020 The Asia Pacific point of care (PoC) diagnostics market is expected to reach USD 5,427.1 million by 2020, according to a new study by Grand View Research, Inc. Growing base of geriatric population and the ability to render immediate results and improve patient care coupled with rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records) are expected to drive demand over the next six years. Skilled staff shortages, especially pertaining to the field of diagnostics are also expected to accelerate the market penetration rates of PoC products, by expediting lab automation processes. Rising demand for home healthcare and other healthcare establishments catering to the elderly population and initiatives undertaken by governments to shorten hospital stays by establishing out-patient care models are also expect
Read more

Latin America Nutrition & Dietary Supplements Market Expected To Grow At A CAGR 8.8% For The Forecast Period From 2017 To 2025 : Grand View Research Inc.

San Francisco, 20 May 2019:  The Report  Latin America Nutrition & Dietary Supplements Market  Size, Share & Trends Analysis Report By Formulation, By Function (Medical Foods, Sports Nutrition), By Consumer, By Country, And Segment Forecasts, 2018 – 2025 The Latin America Nutrition & Dietary Supplements Market size is expected to reach USD 47.5 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 8.8% over the forecast period. Growing expenditure on nutrition and dietary supplements, disposable income, and consumer awareness are some of the key market drivers. Changing regulatory framework to ensure drug safety in Latin American countries such as Mexico and Argentina is also expected to positively impact market growth in the forthcoming years. Growing demand for nutrition and dietary supplements among geriatric population is also one of the considerable market drivers. Nutrition plays a vital role in maintain
Read more

Biomaterials Market Size Poised To Reach USD 348.4 Billion By 2027

Image
  San Francisco, 15 Dec 2020:   The Report  Biomaterials Market  Size, Share & Trends Analysis Report By Product (Natural, Metallic, Polymer), By Application (Cardiovascular, Orthopedics, Plastic Surgery), By Region, And Segment Forecasts, 2020 - 2027 The global biomaterials market size is expected to reach USD 348.4 billion by 2027, registering a CAGR of 15.9% over the forecast period, according to a new report by Grand View Research, Inc. The application of biomaterials represents a fast-growing field in biomedical research. Recent advances in the improvement of bioactivity, compatibility, and mechanical properties of biomaterials have introduced new opportunities for their application in tissue engineering, immune engineering, and drug delivery systems. Biocompatibility, low toxicity, and renewable nature of polymeric biomaterials make them potent drug delivery agents in controlled and targeted drug delivery, thus providing lucrative opportunities for the market growth. The adve
Read more